Navigation Links
Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
Date:3/4/2008

in the Company's Form 10-K for the fiscal year ended

December 31, 2006

Vermillion, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(In Thousands, Except Per Share Amounts)

(Unaudited)

Three Months Ended Year Ended

December 31, December 31,

2007 2006 2007 2006

Revenue $23 $1,216 $44 $18,215

Cost of revenue 13 506 28 9,338

Gross profit 10 710 16 8,877

Operating expenses:

Research and

development 1,916 2,693 8,213 11,474

Sales and marketing 735 1,916 2,175 12,568

General and

administrative 2,232 3,112 10,858 10,661

Total operating expenses 4,883 7,721 21,246 34,703

Gain on sale of

instrument business 1,992 6,929 1,610 6,929

Loss from operations (2,881) (82) (19,620) (18,897)

Loss on extinguishment

of debt - (1,481) - (1,481)

Interest and other

expense, net (247) (326) (1,499) (1,536)

Loss before income

taxes (3,128) (1,889) (21,119) (21,914)

Income tax benefit

(expense) (164) 38 (163) (152)

Net loss $(3,292) $(1,851) $(21,282) $(22,066)

Loss per share -

basic and diluted (1) $(0.52) $(0.49) $(4.47) $(6.05)

Shares used to

compute basic and

diluted loss per

common sha
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
10. Access Highlighted in Recent BusinessWeek Article
11. ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Md. , Aug. 19, 2014   ... biotechnology company developing novel anti-infective biologic and drug ... and diseases, announced today that its novel ... at the 54 th Interscience Conference on ... Washington D.C. ...
(Date:8/18/2014)... A new therapy developed by researchers at the ... Medicine and Columbia University Medical Center (CUMC) may ... disease treatment. , The researchers demonstrated in ... could selectively inhibit blood vessel re-narrowing and simultaneously ... a balloon catheter to open narrowed or blocked ...
(Date:8/18/2014)... and data storage may someday run on ... to read and write digital information, outperforming ... But ferroelectrics must first overcome a few ... of "forgetting" stored data. , Now, ... Brookhaven National Laboratory have discovered nanoscale asymmetries ...
(Date:8/18/2014)... 18, 2014 TNI BioTech, Inc. (OTC-BB: TNIB) ... manufacturing and marketing of innovative therapies for autoimmune diseases ... providing a second notice of TNI BioTech,s annual meeting ... announcement, Noreen Griffin , founder and CEO of ... your participation in the Annual Meeting. On behalf of ...
Breaking Biology Technology:Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 4Selective therapy may improve artery repair after interventional cardiovascular procedures 2Selective therapy may improve artery repair after interventional cardiovascular procedures 3Promising ferroelectric materials suffer from unexpected electric polarizations 2Promising ferroelectric materials suffer from unexpected electric polarizations 3Promising ferroelectric materials suffer from unexpected electric polarizations 4TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 2TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 3TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 4
... GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX), an ... estimated $15,000,000 Integrated Preclinical/Clinical AIDS,Vaccine Development [IPCAVD] ... This large Grant was awarded by ... & Infectious Disease [NIH-NIAID], an,agency of the ...
... ANN ARBOR, Mich., Sept. 26 MichBio, the,association for ... to be held October 16 in East Lansing. Michigan ... the free event on,its campus. Career Day is intended ... state to educational and career opportunities in,the life sciences. ...
... The landscape of scientific,publications strategy, planning and ... Half of global publications groups are fully,located in ... shift,to medical groups to increase clinical presentation, according ... In a benchmarking study that included such ...
Cached Biology Technology:U.S. Government Awards $15 Million Grant to GeoVax Labs' HIV/AIDS Vaccine Program 2U.S. Government Awards $15 Million Grant to GeoVax Labs' HIV/AIDS Vaccine Program 3MichBio Announces Student Career Day at Michigan State University 2Industry Executives Finding Value in Shift of Scientific Publications 2
(Date:8/19/2014)... bigger brains than counterparts that don,t care for offspring, ... Stickleback fish are well known in the animal kingdom ... rather than the female, cares for offspring. Male sticklebacks ... to find out if the difference in size might ... the study, published recently in Ecology and Evolution ...
(Date:8/18/2014)... The specific composition of bacterial species in a person,s ... Campylobacter , the most common cause of human bacterial ... mBio , the online open-access journal of the American ... Campylobacter infection can yield lasting changes to one,s ... a long time that the microbiota, or microorganisms in ...
(Date:8/18/2014)... Ohio Fish species native to a major Arizona ... habitat by 2050 as surface water flow is reduced ... , Most of these fish species, found in the ... survival relies on easy access to various resources throughout ... the speckled dace (Rhinichthys osculus), roundtail chub (Gila robusta) ...
Breaking Biology News(10 mins):What's in your gut? Certain bacteria may influence susceptibility to infection 2Climate change will threaten fish by drying out Southwest US streams, study predicts 2Climate change will threaten fish by drying out Southwest US streams, study predicts 3
... Spanish and French researchers has undertaken a pioneer analysis ... Areas (MPA) in the Mediterranean and the impact that ... a guarantee for conserving this species., Mediterranean red coral ... jewellery since ancient times. But intensive fishing, particularly in ...
... The U.S. Environmental Protection Agency (EPA) has awarded ... their work in eight key environmental areas: monitoring ... drinking water monitoring, hazardous waste monitoring, water infrastructure, ... year, the companies received "proof of concept" awards ...
... Tufts University,s School of Arts and Sciences has received ... will house a Collaborative Cluster in Genome Structure and ... bring together experts in such areas as genome structure ... to focus on "genome to organism" research to advance ...
Cached Biology News:Marine protected areas conserve Mediterranean red coral 2EPA awards small businesses to develop new environmental technologies 2Tufts wins NCRR grant for Collaborative Cluster in Genome Structure and Developmental Patterning 2Tufts wins NCRR grant for Collaborative Cluster in Genome Structure and Developmental Patterning 3
... Ac-DEVD-CHO is an inhibitor ... The concentration of inhibitor ... activity must be determined ... Ten micromolar inhibitor is ...
Human RELT/TNFRSF19L MAb (Clone 238104)...
homeo box D3, mRNA...
Human TSLP MAb (Clone 258136)...
Biology Products: